Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia

Phase 1

Completed

Conditions: Encephalopathy, Hypoxic-Ischemic

Interventions: Drug: Clonidine (Duraclon®)

First Posted Date: 2013-05-24

Last Posted Date: 2018-01-05

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 13

Registration Number: NCT01862250

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Diet and Migraine Study

Not Applicable

Terminated

Conditions: Migraine
Obesity

Interventions: Other: Low carbohydrate diet
Other: AHA diet recommendations
Other: Low calorie low fat diet

First Posted Date: 2013-05-21

Last Posted Date: 2015-09-02

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 32

Registration Number: NCT01859052

Locations: 🇺🇸
The Johns Hopkins Bayview Headache Center, Baltimore, Maryland, United States

Prospective Randomized Trial of Anterograde Single Balloon Versus Spirus Enteroscopy

Terminated

Conditions: Gastrointestinal Hemorrhage
Inflammatory Bowel Disease
Gastrointestinal Neoplasms

Interventions: Procedure: Single Balloon
Procedure: Spirus

First Posted Date: 2013-05-14

Last Posted Date: 2013-05-14

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 30

Registration Number: NCT01853241

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Randomized Trial for Pain Management in Low-grade Subarachnoid Hemorrhage

Phase 2

Terminated

Conditions: Headaches Associated With Subarachnoid Hemorrhage (SAH)

Interventions: Drug: Standard IV fentanyl bolus
Drug: Low dose fentanyl PCA

First Posted Date: 2013-05-10

Last Posted Date: 2017-06-22

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 1

Registration Number: NCT01851720

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Prevention of Alcohol Intolerance

Phase 2

Completed

Conditions: Alcohol Sensitivity

Interventions: Drug: Broccoli Sprout Extract
Drug: Placebo

First Posted Date: 2013-05-03

Last Posted Date: 2017-09-29

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 30

Registration Number: NCT01845220

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis

Withdrawn

Conditions: Autoimmune Pancreatitis
Cellular Diagnosis, Pancreatic Cancer

First Posted Date: 2013-05-03

Last Posted Date: 2019-01-10

Lead Sponsor: Johns Hopkins University

Registration Number: NCT01845467

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

The Self-Collection Study: a Study of Self-collected HPV Testing and Results Counseling

Not Applicable

Completed

Conditions: HIV Infection

Interventions: Other: Usual Care
Other: Self-Collected HPV Test

First Posted Date: 2013-04-30

Last Posted Date: 2017-12-12

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 97

Registration Number: NCT01843478

Locations: 🇺🇸
Moore Clinic for HIV Care, Johns Hopkins Hospital, Baltimore, Maryland, United States

Seek, Test, Treat Strategies for Vietnamese Drug Users: A Randomized Controlled Trial

Not Applicable

Completed

Conditions: Addiction
HIV

Interventions: Other: Integrated methadone and antiretroviral therapy (iMART) clinic

First Posted Date: 2013-04-26

Last Posted Date: 2016-10-06

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 378

Registration Number: NCT01841320

Locations: 🇻🇳
Tu Liem Medical Center, Hanoi, Vietnam

High-dose Cyclophosphamide for Severe Refractory Crohn Disease

Phase 1

Withdrawn

Conditions: Crohn's Disease
Crohn Disease

Interventions: Drug: High-dose Cyclophosphamide

First Posted Date: 2013-04-19

Last Posted Date: 2018-08-13

Lead Sponsor: Johns Hopkins University

Registration Number: NCT01836289

Modified Atkins Diet Plus KetoCal for Adult Epilepsy

Not Applicable

Completed

Conditions: Epilepsy
Seizure
Medically Resistant Epilepsy
Medically Resistant Seizures

Interventions: Dietary Supplement: Modified Atkins diet
Dietary Supplement: KetoCal

First Posted Date: 2013-04-18

Last Posted Date: 2018-08-31

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 80

Registration Number: NCT01834482

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy